Search clinical trials for: Sodium-glucose cotransporter 2 inhibitors (SGLT2i)
Total 1656 results
-
Ain Shams UniversityNot yet recruitingNephrotic Syndrome
-
AstraZenecaBristol-Myers SquibbCompleted
-
AstraZenecaRecruitingHeart Failure and Impaired Kidney FunctionSpain, United States, France, Germany, Italy, Argentina, Czechia, Vietnam, Peru, China, Philippines, Saudi Arabia, Taiwan, Australia, Austria, Canada, Japan, Malaysia, Poland, Thailand, Israel, Brazil, Finland, Greece, United Kingdom, Mexico and more
-
Korea University Anam HospitalAstraZenecaUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
Qianfoshan HospitalActive, not recruiting
-
Beijing Chao Yang HospitalBeijing Boren Hospital; Beijing Chuiyangliu HospitalNot yet recruitingM-protein Related Cardiac Disease
-
Zhujiang HospitalThird Affiliated Hospital, Sun Yat-Sen University; Peking University Shenzhen... and other collaboratorsCompletedType 2 Diabetes MellitusChina
-
Asmaa Abdelfattah ElsayedCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, Germany, India, Ireland, Japan, Switzerland
-
Steno Diabetes Center CopenhagenZealand University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark and other collaboratorsNot yet recruitingCardiovascular Diseases | Heart Failure | Type 1 Diabetes | Kidney Failure
-
Instituto Nacional de Cardiologia Ignacio ChavezBoehringer Ingelheim laboratoryNot yet recruitingHeart Failure | Congenital Heart Disease | Heart Failure With Reduced Ejection FractionMexico
-
EMSRecruitingDyslipidemia Associated With Type II Diabetes MellitusBrazil
-
EMSNot yet recruitingType 2 Diabetes Mellitus | Dyslipidemia
-
M.H.H. KramerActive, not recruitingType2 DiabetesNetherlands
-
AstraZenecaRecruitingChronic Kidney DiseaseSpain, Italy, China, Vietnam, United States, Brazil, Canada, Malaysia, Poland, Taiwan, Austria, Japan, Turkey, Bulgaria, Chile, United Kingdom
-
The Deutsche Diabetes Forschungsgesellschaft e.V.Novo Nordisk A/S; Boehringer Ingelheim; Federal Ministry of Health, Germany; German... and other collaboratorsRecruitingType 2 Diabetes | Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Germany, Austria
-
Novartis PharmaceuticalsCompleted
-
Mostafa BahaaRecruitingInflammatory Bowel DiseasesEgypt
-
Tanta UniversityEman Ibrahim Elberri, Faculty of Pharmacy, Tanta University; Fedaa Abd El-monem... and other collaboratorsRecruiting
-
AstraZenecaCompletedBioequivalence | Fixed Dose Combination Tablets | Healthy Male and Female SubjectsUnited States
-
AstraZenecaBristol-Myers SquibbTerminatedType 2 Diabetes MellitusUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Peking Union Medical College HospitalChinese Academy of SciencesUnknown
-
Merck Sharp & Dohme LLCPfizerCompleted
-
SanofiCompletedDiabetes MellitusFrance
-
Imperial College LondonRoyal Brompton & Harefield NHS Foundation TrustNot yet recruitingHeart Diseases | Heart Failure | Cardiomyopathies | Cardiomyopathy, Dilated
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Cytomegalovirus RetinitisUnited States
-
Janssen Research & Development, LLCCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2United States
-
Weill Cornell Medical College in QatarUniversity of Hull; Hamad Medical Corporation; Sidra Medical and Research CenterActive, not recruiting
-
RenJi HospitalRecruitingObesity | Chronic Kidney DiseasesChina
-
Stanford UniversityCompleted
-
Steno Diabetes Center CopenhagenUniversity Medical Center GroningenWithdrawnDiabetic Nephropathy Type 2Denmark
-
University Medical Center GroningenAstraZenecaCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Diabetes Complications | Chronic Kidney Diseases | Proteinuria | Albuminuria | CKD | Chronic Kidney Disease Due to Type 2 Diabetes Mellitus | Diabetes Mellitus Type 2 With ProteinuriaNetherlands
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
Genentech, Inc.Roche Pharma AGCompleted
-
AstraZenecaRecruitingLiver CirrhosisDenmark, Spain, Germany, United States, France, Australia, China, Netherlands, Belgium, Switzerland, Austria, United Kingdom, Taiwan, Canada, Czechia
-
Boehringer IngelheimCompleted
-
Eisai Co., Ltd.Completed
-
Eisai Inc.TerminatedRefractory Partial Onset SeizuresUnited States
-
Herlev HospitalUniversity of Copenhagen; The Danish Medical Research Council; The Danish Diabetes...Completed
-
Wuhan Union Hospital, ChinaPeking University First HospitalRecruitingCardiovascular Diseases | Coronary Disease | Diabetes Mellitus, Type 2China
-
University of CopenhagenHvidovre University HospitalCompleted
-
Aspen Global IncorporatedTerminatedHeparin-induced ThrombocytopeniaUnited States, Bosnia and Herzegovina, Canada, France, Germany, Italy, Poland, Russian Federation, Serbia
-
AstraZenecaCompleted
-
The University of Texas Health Science Center at...National Cancer Institute (NCI)CompletedColorectal CancerUnited States
-
Chong Kun Dang PharmaceuticalCompletedReflux EsophagitisKorea, Republic of